Interstellar Testing Centre Private Limited, a wholly owned subsidiary of Qualitek Labs , has secured two work orders from Indian Oil Corporation Limited (IOCL) aggregating to Rs 3.77 crore. The contracts encompass the operation and management of a 2G Ethanol QC Laboratory, alongside testing services for water, wastewater, ethanol, and process chemicals. These orders are significant for the subsidiary as they expand its engagement with a major domestic entity in the energy sector.

The first work order pertains to the Lab operation & Management Contract of the 2G Ethanol QC Laboratory, valued at Rs 3,01,50,000 inclusive of GST. The second order is for the Testing of Water/ Wastewater, Ethanol, Process Chemicals, with a contract value of Rs 75,40,200 inclusive of GST. Both orders were awarded by a domestic entity, IOCL, and do not involve any related party transactions or interests from the promoter group.

Contract Details

The duration for both contracts is set at 24 months. For the lab operation and management contract, the period commences from the date of handing over of the site, which is scheduled to occur within 15 days from the date of issuance of the GeM Contract. The testing services contract is set to run for 24 months starting July 2, 2026.

The disclosure was made to the Bombay Stock Exchange on June 25, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information is also available on Qualitek Labs Limited's official website.

Qualitek Labs Limited has filed its investor presentation for the half-year and full year ended March 31, 2026, with the Bombay Stock Exchange. The presentation details the company's financial performance, operational highlights, and strategic initiatives for the period. The company reported robust growth across consolidated and standalone metrics driven by recent acquisitions and operational expansion.

Consolidated Financial Performance

For the financial year ended March 31, 2026, the company reported a consolidated net profit of ₹14.60 Crore, a rise of 90% from ₹7.68 Crore in the previous year. Revenue from operations increased to ₹124.52 Crore, up 77% from ₹70.23 Crore in FY25. Total income for the period stood at ₹125.05 Crore. The basic and diluted earnings per share (EPS) for the year were recorded at ₹13.4, compared to ₹7.08 in the prior year. EBITDA for the full year grew 80% to ₹29.29 Crore, with an EBITDA margin of 24%.

Key Consolidated Metrics

Standalone Financial Results

On a standalone basis, Qualitek Labs Limited reported a net profit of ₹8.0 Crore for FY26, an increase of 51% from the previous year. Revenue from operations for the year stood at ₹67.60 Crore, compared to ₹45.86 Crore in FY25. Basic and diluted EPS for the standalone entity were ₹7.3, up from ₹5.94 in the preceding year. For H2 FY26, standalone revenue was ₹38.6 Cr, while PAT stood at ₹5.2 Cr.

Key Standalone Metrics

Corporate Developments and Outlook

The company outlined a capital expenditure plan of INR 63 Crore for FY2026-27. Strategic initiatives include geographic expansion in Transport and Minerals segments, capacity expansion of Food labs, and the establishment of new revenue streams such as EMI/EMC in Pune and an analytical lab in Noida. The company also plans to pursue M&A opportunities across Pharma, Food, and Electricals & Electronics segments.